The MoxR family of AAA+ ATPases is widespread throughout bacteria and archaea but remains poorly characterized. We recently found that the Escherichia coli MoxR protein, RavA (Regulatory ATPase variant A), tightly interacts with the inducible lysine decarboxylase, LdcI/CadA, to form a unique cage-like structure. Here, we present the X-ray structure of RavA and show that the αβα and all-α subdomains in the RavA AAA+ module are arranged as in magnesium chelatases rather than as in classical AAA+ proteins. RavA structure also contains a discontinuous triple-helical domain as well as a β-barrel-like domain forming a unique fold, which we termed the LARA domain. The LARA domain was found to mediate the interaction between RavA and LdcI. The RavA structure provides insights into how five RavA hexamers interact with two LdcI decamers to form the RavA-LdcI cage-like structure.
The MoxR family of AAA+ ATPases is widespread throughout bacteria and archaea but remains poorly characterized. We recently found that the Escherichia coli MoxR protein, RavA (Regulatory ATPase variant A), tightly interacts with the inducible lysine decarboxylase, LdcI/CadA, to form a unique cage-like structure. Here, we present the X-ray structure of RavA and show that the αβα and all-α subdomains in the RavA AAA+ module are arranged as in magnesium chelatases rather than as in classical AAA+ proteins. RavA structure also contains a discontinuous triple-helical domain as well as a β-barrel-like domain forming a unique fold, which we termed the LARA domain. The LARA domain was found to mediate the interaction between RavA and LdcI. The RavA structure provides insights into how five RavA hexamers interact with two LdcI decamers to form the RavA-LdcI cage-like structure.
acid stress | alarmone P roteins of the AAA+ superfamily (ATPases Associated with diverse cellular Activities) are highly ubiquitous and found in all kingdoms of life. These proteins are characterized by the structural conservation of a central ATPase domain of about 250 amino acids called the AAA+ module (1, 2) . AAA+ ATPases employ the energy derived from ATP hydrolysis to remodel proteins, DNA, or RNA. Typically, the AAA+ domain can be divided into two structural subdomains, an N-terminal P-loop NTPase αβα subdomain that is connected to a smaller C-terminal all-α subdomain. The αβα subdomain adopts a Rossman fold and contains several motifs involved in ATP binding and hydrolysis, including Walker A, Walker B, and Sensor 1 signature sequences (3) (4) (5) (6) . The all-α subdomain, which contains the Sensor 2 motif (7), is much less conserved across AAA+ proteins.
AAA+ proteins form oligomers, usually hexameric rings, in the presence of nucleotides (8) . The ATP-binding pocket is located at the interface between two neighboring subunits. A highly conserved arginine from one subunit, called an "arginine finger," contacts the γ-phosphate of bound ATP of the neighboring subunit (9) . AAA+ proteins typically go through a cycle of ATP binding, hydrolysis, and release of products. This reaction cycle results in a series of conformational changes and mechanical movements that allow these proteins to exert their activity either directly or through domains attached to the AAA+ domain (3, 10) .
The RavA protein (Regulatory ATPase Variant A) belongs to the MoxR AAA+ family (11) . Limited experimental data suggest a function of MoxR AAA+ proteins as chaperones in the assembly of multimeric complexes and a possible role in small molecule cofactor insertion/removal (11) . However, how these proteins act is not clear. In Escherichia coli, the ravA gene is in an operon with another gene of unknown function, which we termed viaA, and the operon is under the control of σ S promoter, suggesting a function of RavA and ViaA under stress conditions (12) . This is further substantiated by our discovery that RavA physically interacts with the inducible lysine decarboxylase enzyme, LdcI/CadA, a key enzyme in the bacterial acid stress response. We have visualized the LdcI-RavA complex by negative staining electron microscopy and found it to form a large, about 3.3 MDa, unusual cagelike structure consisting of two LdcI decamers that are linked by up to five RavA hexamers (12) . Because LdcI is fivefold symmetric whereas RavA is sixfold symmetric, understanding the construction of this complex is important to understanding how the symmetry mismatch was used in forming the cage-like structure.
We recently solved the X-ray crystal structure of LdcI decamer and unexpectedly found that LdcI activity is strongly inhibited by the binding of the alarmone, ppGpp (further details on the LdcI structure will be described elsewhere). Here, we have determined the three-dimensional structure of RavA full-length protein as a monomer in complex with ADP by X-ray crystallography. Insights into the intersubunit organization of the hexameric RavA were obtained from electron microscopy. These structures provided important insights into how nature solved the symmetry mismatch problem between the fivefold symmetric LdcI decamer and sixfold symmetric RavA hexamer to allow for the construction of the RavA-LdcI molecular cage-like structure. We show that the RavA-LdcI interaction reduces the inhibition of LdcI activity by the alarmone ppGpp in vitro as well as in vivo. The biological implications of this interaction are discussed.
Results
The Overall Structure of RavA Protomer. RavA full-length recombinant protein was expressed and purified to homogeneity as previously described (12) . Purity was tested by mass spectrometry and light scattering. RavA crystals were obtained several years ago but failed to diffract to better than 7 Å resolution. Highquality crystals were finally obtained by employing a dehydration protocol as described in Materials and Methods. The protein crystallized in the space group P6 5 with one molecule in the asymmetric unit. The crystal structure was solved to 2.9
Å resolution. The model includes 475 of the 498 residues of RavA and one bound ADP molecule, but no electron density corresponding to a Mg 2þ ion was found (Table S1 ). Two segments, 88-97 and 438-441 (Fig. 1A) , are missing in the final electron density map and are indicated by dotted lines in Fig. 1B . The RavA monomer has a complex elongated overall structure consisting of three distinct domains ( Fig. 1 A and B) . The N-terminal domain of RavA is the AAA+ module, which is composed of two subdomains: the αβα subdomain (residues 1-192, brown) and the all-α subdomain (residues 226-306, wheat). The αβα subdomain exhibits a Rossmann-type fold commonly found in nucleotide binding proteins. It consists of a central β-sheet with five parallel β-strands, ordered as 51432, sandwiched between seven α-helices. The all-α subdomain consists of four antiparallel α-helices. The αβα subdomain and the all-α subdomain are linked by a 32-residue helical segment (residues 193-225, green). The relative arrangement of the subdomains is similar to that found in Mg chelatases (discussed below).
The second domain is a discontinuous triple-helical domain formed by helices α13, α15, and α16 (residues 307-330 and 442-497, light blue). This domain has a rigid structure stabilized by hydrophobic interactions localized at the interface between the three helices. The third domain (residues 331-437, dark blue), which we have named the LARA domain (for reasons described below), is a protuberance between helices α13 and α15 of the triple-helical domain. As shown in Fig. 1 B and C, the LARA domain forms a compact antiparallel β-barrel-like structure consisting of six β-strands (β6-β11) and one α-helix (α14). The LARA domain also includes an N-terminal flexible region (residues D332-S360). The domain is very basic (pI of 9.6) resulting from a highly positively charged surface formed by residues R340, R347, R348, R398, K400, K409, and R423 (Fig. 1C) . We performed an extensive search for structures similar to that of the LARA domain in the Protein Data Bank using secondary-structure matching (SSM) (13) and Dali (14) , but no such structures were found. Hence, we conclude that the E. coli RavA LARA domain adopts a unique fold.
The sequence conservation at the C terminus of RavA spanning the triple-helical and LARA domains diverges quite quickly, although, according to secondary-structure prediction, all organisms containing RavA protein with a LARA domain also have a triple-helical domain. It was surprising to find that a phenylalanine (F472), located at the turn between helices α15 and α16 of the triple-helical domain, is absolutely conserved (Fig. S1A ). This phenylalanine makes hydrophobic contacts with the AAA+ module and, hence, anchors the triple-helical bundle to the AAA+ module ( Fig. S1 B and C) . F472 might serve to transmit the nucleotide-dependent conformational changes in the AAA+ domain to the C-terminal triple-helical and LARA domains of RavA.
RavA Hexameric Assembly. Although RavA and many other AAA+ ATPases crystallize as monomers, their functional form is well known to be an oligomeric ring structure. Previous work in our laboratory provided first evidence for a hexameric assembly of RavA induced by ATP, ADP, or 5′-adenylyl-β,γ-imidodiphosphate (AMPPNP) binding (12) . Here we present a 3D structure of the RavA hexamer formed in the presence of ADP obtained by negative staining electron microscopy (EM) and image analysis.
Similar to other AAA+ protein structures, hexameric RavA-ADP is characterized by a ring-shaped core surrounding a central pore. Some representative class averages, as well as corresponding projections of the 3D structure at similar orientations, are shown in Fig. 2A . The distinctive feature of the class averages is the relatively weak density of the LARA domain, which necessitated a good alignment in order to be properly visualized (see Materials and Methods for details). The RavA hexameric ring forms a rather unique flower-like structure and is found to be about 220 Å in diameter and of 80-Å thickness, whereas the diameter of the central channel is about 25 Å. The 3D reconstruction possesses a prominent handedness, visible in the core AAA+ part and notably accentuated by the protrusions. An atomic model of the hexamer was then generated by docking the crystal structure of the monomer into the EM density of the hexamer and adjustment of the resulting intersubunit contacts based on a homology model generated from the hexameric crystal structure of HslU [PDB ID code 1DO0 (15) ] (see Materials and Methods and Fig. S2 for details) . The final EM reconstruction and the resulting atomic model of the RavA-ADP hexamer are shown in Fig. 2B .
The Organization of the AAA+ Motor Subdomains. In their classification of AAA+ proteins, Aravind and coworkers grouped RavA within the helix 2 insert clade (8) . Members of this family are found to have (i) an insert within helix 2 of the conserved ASCE (refers to Additional Strand, Catalytic E) division P-loop ATPase core, (ii) a β-hairpin N terminal to Sensor 1, as well as, (iii) a long helical seg- αβα subdomain is shown in brown, all-α subdomain is shown in wheat, the linker between the two subdomains is shown in green, triplehelical bundle domain is shown in blue, the LARA domain is shown in dark blue, and bound ADP is shown in violet. The α-helices and β-strands are labeled sequentially except for β a and β b of the Pre-Sensor 1 β-Hairpin insertion. Residues 88-97 and 438-441 were not observed in the X-ray structure and are indicated by a dashed line. The figure was generated using PYMOL.
(C) Shown is a topological diagram of the LARA domain drawn using TopDraw (25) and its electrostatic surface potential calculated using Delphi (26) . Colors are according to the calculated electrostatic surface potential and range from red (potential of −5 kT) to blue (þ5 kT). The hydrophobic core of the domain is made by the side chains of hydrophobic residues from each of the β-strands (β1: L362, L364, L366, L372; β2: V377, I380, F382; β3: I397, L401; β4: L410, L412; β5: L420, V422; β6: L432) as well as residues L387, W390 and L391 from the α14 helix.
ment separating the C terminus of the αβα subdomain and the N terminus of the all-α subdomain. The X-ray structure of the RavA AAA+ module agrees with this classification. The αβα subdomain contains two characteristic β-hairpin insertions (Figs. 1A and 2C). The helix-2 insert (H2-I, residues Pro85-Pro106) is incorporated within helix α4, but is partially unstructured in our model (shown as a dotted line in Figs. 1B and 2C ). In the case of the Mg chelatase subunit BchI, this insert consists of two β-strands flanking a small helix (16) . The Pre-Sensor 1 β-Hairpin insertion (PS1-βH, residues Gln135-Pro146) is incorporated between the Sensor 1 strand (β4) and the preceding helix (α5). It has been shown that PS1-βH and H2-I are usually important for substrate interaction (17) (18) (19) (20) . The long helical segment between the αβα and all-α subdomains is shown in green in Figs. 1 A and B and 2C; this segment consists of two helices that wrap around the surface of the αβα subdomain making several contacts with it. SSM and Dali structural similarity searches using the whole RavA AAA+ module indicated only four proteins to have similar structures as the RavA AAA+ domain: the putative ATPase from Cytophaga hutchinsonii, BchI subunit of Rhodobacter capsulatus Mg chelatase, archaeal minichromosome maintenance protein MCM from Sulfolobus solfataricus, and an archaeal MCM homolog from Methanopyrus kandleri (Fig. S3) . In all of these proteins, the spatial localization of the all-α subdomain relative to the αβα subdomain is similar to that of RavA and is significantly different from its typical position found in most other AAA+ members (8, 21) . Fig. 2C illustrates the differences between the AAA+ module organization of HslU, a canonical model of the typical AAA+ module fold (15) , and RavA AAA+ domain. In HslU, the all-α subdomain is located on "top" of the αβα subdomain. In the all-α subdomain, the Sensor 2 motif (shown in dark blue in Fig. 2C ), a required motif for nucleotide binding and hydrolysis, is oriented toward the ATP-binding site of the same protomer. In the case of RavA, the all-α subdomain is on the "right" of the αβα subdomain; consequently, the Sensor 2 motif cannot contribute to ATP hydrolysis on the same protomer as in HslU. However, when the X-ray structure of the HslU hexamer is compared to the RavA hexameric model (Fig. 2D) , then it is clear that HslU and RavA share similar organization of the subdomains in the oligomer although the orientation of the protomers is reversed. In the RavA hexamer, the all-α subdomain of one protomer is located on top of the αβα subdomain of the protomer on its right (Fig. 2 D  and E) , and the Arg residue of Sensor 2 faces the ATP-binding site of a neighboring protomer (Fig. 2E and Fig. S4 ). In the HslU hexamer, the all-α subdomain of one protomer is located on top of the αβα subdomain of the protomer on its left (Fig. 2 D and E) , and the Arg residue of Sensor 2 is facing the ATP-binding site of the same protomer ( Fig. 2E and Fig. S4 ). Hence, when viewed from the top, the subunits in RavA are organized clockwise, whereas the subunits in HslU are organized counterclockwise (Fig. 2D ). It should be noted that, in the RavA structure, the all-α and αβα subdomains from the same monomer make extensive interactions. The buried surface area between these two subdomains is much larger in the case of RavA (2;797 Å 2 ) than for HslU monomer (1;084 Å 2 ) (Fig. 2E) . As a result, in the HslU hexamer, the all-α subdomain makes more extensive interactions with the αβα subdomain of the neighboring protomer (2;930 Å 2 ) than in the RavA hexamer (754 Å 2 ). Even with these major differences in the assembly of the subunits, the overall structures of the RavA and HslU AAA+ hexamers remain similar with a high conservation in the organization of the ATP-binding site. Fig. S4 shows the localization of the nucleotide between two subunits of the RavA and HslU hexamers. In both cases, the nucleotide makes contact with three subdomains. For HslU, the nucleotide is sandwiched between the αβα and the all-α subdomains of the same subunit and faces the αβα subdomain of the left neighboring subunit, whereas the nucleotide in RavA contacts the αβα subdomain of one subunit and faces the all-α and the αβα subdomains of the left neighboring subunit.
The LARA Domain Mediates RavA-LdcI Interactions. Previous work in our laboratory has shown that RavA interacts with LdcI, an inducible lysine decarboxylase enzyme, forming an unusual cagelike complex of about 3.3 MDa consisting of two LdcI (81 kDa) decamers and up to five RavA (56 kDa) hexamers ( Fig. 3A ) (12) . We further confirmed this interaction in this study. The pull-down of RavA from an E. coli strain in which a Sequential Peptide Affinity (SPA) tag (22) was fused at the 3′ end of the endogenous ravA gene, also pulled down LdcI as previously observed (12) . Analysis of the complex by size exclusion chromatography showed that the majority of RavA was part of a 3.3-MDa complex with LdcI ( Fig. S5A) , which corresponds to the mass of the complex shown in Fig. 3A . LdcI migrated as a complex with RavA but also as uncomplexed decamers as well. In another experiment, analysis of the interaction between purified RavA and LdcI proteins by sedimentation velocity analytical ultracentrifugation revealed the presence of 0.8-, 2.7-, and 6.0-MDa complexes (Fig. S5B ). These complexes would correspond to LdcI decamer alone, the RavA-LdcI cage-like complex of Fig. 3A , and a dimer of the cage-like complex, respectively.
Docking of RavA hexameric model of Fig. 2B and LdcI decameric crystal structure that we recently determined into the EM envelope suggested that the LARA domain of RavA might interact with LdcI ( Fig. 3A and Fig. S6A ). To determine the validity of the docking model, a RavA construct was made in which the LARA domain was deleted and was termed RavAΔLARA (consisting of residues Met1-Ala335 and Leu434-Cys498). An isolated LARA domain construct was also generated (residues Gln329-Glu440). Circular dichroism analysis showed that both proteins have the expected secondary-structure content. Furthermore, RavAΔLARA formed a hexameric complex in the presence of ATP (Fig. S6B) , and its ATPase activity was similar to that of WT RavA (Fig. S6B, Inset) . The interaction of LdcI with RavA and its different constructs was then assessed by surface plasmon resonance (SPR) using the Biacore system. In these experiments, LdcI was immobilized on the chip. The SPR experiments clearly showed that, although WT RavA and LARA domain do interact with LdcI ( Fig. 3B ), RavAΔLARA does not bind to LdcI (Fig. 3C ). In the absence of nucleotide, WT RavA bound LdcI with an apparent binding constant of 0.56 μM (Fig. 3B ). In the presence of ATP, the binding curve was best fit using two independent binding sites with apparent binding constants of 0.018 μM and 1.22 μM (Fig. 3B ). This might indicate that the proper hexamerization of RavA, which is attained in the presence of ATP, allows for two RavA"legs" to bind the LdcI decamer at two different sites as suggested by the docking analysis of Fig. 3A and Fig. S6A . However, it should be noted that, because of the experimental setup, the full complex shown in Fig. 3A , in which RavA hexamers can bridge two LdcI decamers, is unlikely to form under the conditions of the SPR experiments because LdcI is cross-linked to the chip. The isolated LARA domain is also able to bind LdcI albeit with a lower apparent K d of 54 μM (Fig. 3B) . Hence, these observations strongly suggest that the LARA domain is the RavA domain required for LdcI interaction, hence the acronym LARA: LdcI associating domain of RavA.
Bioinformatic analysis provided further support for the finding that the LARA domain mediates the interaction of RavA with LdcI. In 47 representative bacterial strains that contained RavA based on BLAST searches (23), we asked whether these strains also contain LdcI. As mentioned earlier, the C-terminal fragment of RavA including the triple-helical bundle and LARA domain is not well conserved. Hence, the presence of the LARA domain in RavA across the different strains was assessed using JPred sec- ondary structure prediction program (24) . It was interesting to find that RavA in all strains containing LdcI has a LARA domain, whereas strains that do not have LdcI contain RavA that has or does not have the LARA domain (Fig. S6C) . The LARA domain in these strains might have other functions or the domain will eventually degenerate.
The LARA Domain Mediates RavA-RavA Interactions. The docking shown in Fig. 3A suggests that the LARA domain might also mediate RavA-RavA interactions within the RavA-LdcI cage-like complex by interacting with the triple-helical domain and/or the LARA domain of the neighboring RavA (Fig. S6A) . SPR experiments were carried out in which RavA or RavAΔLARA is immobilized on the chip and the LARA domain is titrated. The results indicate that the LARA domain can bind to RavA with an apparent K d of about 0.5 μM (Fig. 3D ). This interaction is drastically reduced when the binding experiment is performed between RavAΔLARA and the LARA domain (Fig. 3D) , suggesting that the LARA domain plays an important role in RavA-RavA interactions within the RavA-LdcI cage-like complex.
RavA Antagonizes the Inhibitory Effect of ppGpp on LdcI Activity. The LdcI crystal structure revealed the presence of a binding site for the bacterial alarmone guanosine tetraphosphate (ppGpp) at the interface between two protomers in the pentameric ring (Fig. 3A) . Biochemical assays showed that ppGpp binding to LdcI results in drastic inhibition of the LdcI activity of approximately 10-fold at pH values greater than 5. The docking shown in Fig. 3A suggests that the LARA domain of RavA might bind at a site in LdcI that could affect ppGpp binding to the decarboxylase. The activity of the decarboxylase was measured in the presence and absence of RavA and ppGpp using an isothermal titration calorimetry (ITC) approach. Initially, we ensured that the presence of GTP, GDP, ppGpp, and pppGpp does not affect RavA ATPase activity (Fig. 4A) . When the RavA-LdcI complex is preformed, LdcI activity is not significantly changed consistent with our prior observations (12) . However, when ppGpp is added to the preformed RavA-LdcI complex, the presence of RavA reduces the inhibitory effect of ppGpp on LdcI by about 40% under the conditions of the experiment (Fig. 4B) . Moreover, the RavA-ΔLARA truncation mutant is not able to reduce the inhibitory effect of ppGpp on LdcI activity, which is consistent with our results showing that the LARA domain is responsible for the RavA-LdcI interaction. When LdcI is preincubated with ppGpp and then RavA is added, RavA is not able to reduce the inhibition of LdcI by the alarmone (Fig. 4C) . Hence, RavA either blocks the access to the ppGpp binding site in LdcI or RavA induces a local conformational change in LdcI that reduces its ppGpp binding affinity. Alternatively, ppGpp might cause a conformational change in LdcI to reduce RavA binding to the decarboxylase.
It should be pointed out that the effect of RavA on LdcI inhibition by ppGpp is probably underestimated because these experiments were done at low concentrations of MgCl 2 . Under such conditions, RavA has low ATPase activity; addition of higher concentrations of MgCl 2 lead to the precipitation of ppGpp by Mg 2þ . To further validate our in vitro results and to determine if the modulation of ppGpp binding to LdcI by RavA can be observed in vivo, the activity of LdcI was tested in different strains undergoing a stringent response. Four strains were used: ΔcadBA, WT + ravA, WT + ravAΔLARA, and WT + ravA(K52Q). The last three strains overexpress RavA, RavAΔLARA, and RavA (K52Q) proteins by IPTG induction (refer to Materials and Methods). RavA(K52Q) is ATPase deficient because the conserved Walker A K52 is mutated to Q (Fig. 1A) . Endogenous RavA is expressed at low levels and is induced only in the stationary phase (12) . Cells were grown to log phase in defined rich media buffered at pH 5, and, when the OD 600 of each strain was approximately 0.2, proteins were induced with 1 mM IPTG for 1 h. Cells were then shifted to minimal media weakly buffered at pH 5 containing no amino acids to induce ppGpp production, and supplemented with 30 mM lysine to follow the LdcI activity by monitoring pH change of the media; no cell growth occurs during this time (Fig. 4D and Fig. S7) . Consistent with the in vitro results, WT + ravA strain increased the pH of the media at a higher rate than the WT + ravAΔLARA strain, whereas no significant pH change was observed for the ΔcadBA cells (Fig. 4D) . Hence, the formation of the RavA-LdcI complex reduced the inhibitory effect of the alarmone on LdcI, allowing the cells to better respond to low acidity. On the other hand, RavAΔLARA cannot form a complex with LdcI (Fig. 3D) and, hence, LdcI should still be inhibited by ppGpp resulting in a lower rate of pH increase, as observed (Fig. 4D) . The strain overexpressing RavA(K52Q) mutant increased pH faster than the strain overexpressing RavA-ΔLARA, but not as well as the strain overexpressing WT RavA (Fig. 4D) , indicating that the binding of RavA to LdcI is not enough to modulate alarmone binding to the decarboxylase, but that the ATPase activity of RavA is also needed.
Discussion
The organization of the AAA+ module of RavA as revealed by the X-ray structure of the protein (Figs. 1B and 2C ) explicitly demonstrates that the protein is closely related to the family of Mg chelatases. We had previously found that RavA and LdcI interact tightly to form an unusual cage-like structure (12) . Having the X-ray structure and the EM reconstruction of RavA (this study), as well as the X-ray structure of LdcI and the negative staining EM reconstruction of the RavA-LdcI complex (12) , allowed us to gain important insights into the design principles of this cage that is formed by the interaction of a fivefold symmetric oligomer of LdcI with a sixfold symmetric oligomer of RavA (Fig. 3A) . The RavA hexamer displays six "legs," which are spanning the triple-helical domain and the LARA domain. Two of the legs interact with an LdcI dimer at the top of the complex, and two other legs show the same set of interactions with an LdcI dimer at the bottom of the complex. These interactions seem to be mainly mediated by the LARA domain. The two remaining legs of RavA are interacting with a neighboring RavA leg on the left and on the right (Fig. 3A and Fig. S6A ). The RavA-RavA leg-leg interactions seem to involve the triple-helical domain, as well as the LARA domain (Fig. 3A) . Hence, the construction of the RavA leg makes all these interactions possible. The LARA domain exhibits a unique fold and, based on the bioinformatic analysis of Fig. S6C , seems to be optimally evolved to mediate the interaction of RavA with LdcI.
The RavA-LdcI cage-like structure might have multiple functions in the cell yet to be elucidated; however, one consequence we found here for the formation of the RavA-LdcI complex is the reduction of the inhibitory effect of ppGpp on LdcI activity. When cells are undergoing acid stress and LdcI is induced to about 2,000 decamers per cell, nutrient limitation will result in the production of the alarmone. Because we estimate that there are about 50-100 RavA hexamers per cell in the stationary phase (12) , only a small population of LdcI molecules is expected to be in complex with RavA. This population of LdcI will not be strongly inhibited by ppGpp, allowing the cells to continue to respond to acid stress at the risk of depleting lysine amounts. It is interesting to note that RavA and ppGpp have similar binding constants to LdcI: K d of 0.02-1 μM for RavA-LdcI interaction (Fig. 3B) and K d of 0.01-0.7 μM for LdcI-ppGpp interaction. The binding of RavA to apo-LdcI does not affect LdcI activity to any significant extent (Fig. 4B and ref. 12) . Hence, there is a fine-tuning of LdcI activity by ppGpp and RavA, which is required for the cells to respond to acid stress, as well as to prevent the depletion of their amino acids. This fine-tuning probably involves other factors and proteins and also occurs for other amino acid decarboxylases involved in the bacterial acid stress response.
Materials and Methods
Details of cloning, protein expression and purification, RavA ATPase assay, SPR measurements, LdcI enzyme kinetics measurements using ITC, sedimentation velocity analytical ultracentrifugation, pull-down experiments, media shift assays, X-ray crystallography, and electron microscopy are provided in SI Text.
ACKNOWLEDGMENTS. We thank Dr. Elisabeth Tillier (University of Toronto) for her help with the bioinformatic analysis shown in Fig. S6C The LARA domain (Gln329-Glu440) was PCR amplified from the p11-RavA plasmid (1). The PCR product was digested with NdeI and BamHI (NEB) and ligated into an empty p11 vector to produce p11-LARA. The resulting construct has an N-terminal His 6 -tag followed by a tobacco etch virus (TEV) cut site that leaves the three residues GHM at the N terminus of the construct after TEV cleavage. The RavAΔLARA (Met1-Ala335 and Leu434-Cys498) was constructed by PCR amplification of two fragments of the ravA gene that bear a BsmBI type-II restriction site using the protocol from ref. 2. Both PCR products were digested with BsmBI, NdeI, and BamHI (NEB) and, subsequently, ligated into an empty p11 vector that had been digested with NdeI and BamHI to generate p11-RavAΔLARA. All constructs were verified by sequencing.
Protein Expression and Purification. RavA and LdcI full-length proteins were purified as described earlier (1) . RavAΔLARA was expressed and purified using the same protocol as that used for WT RavA. The LARA domain was expressed in BL21-gold (DE3) pLysS (Stratagene). The protein was then purified on Ni-NTA resin (Qiagen), a Mono S 5∕50 GL cation exchange column (GE/Amersham), and then on a Superdex 75 10∕300 (GE/Amersham) size exclusion chromatography column. Fractions were pooled, concentrated, and quantified using absorbance.
RavA ATPase Activity. ATP hydrolysis rates were measured as previously described using the malachite green assay (1). Reaction buffer contained 0.1 M Hepes, pH 7.5, 5 mM MgCl 2 , 0.02% Triton X100, 1 mM β-mercaptoethanol, 1 mM ATP, and 250 nM RavA at 37°C. The reaction was also carried out in the absence and presence of 100 μM of GTP, GDP, pppGpp, or ppGpp.
Surface Plasmon Resonance (SPR) measurements. To measure the binding affinities, SPR experiments were performed using BiacoreX instrument (GE Healthcare) at 25°C. The ligand (LdcI or RavA or RavAΔLARA) was attached to a Biacore sensorchip (CM5) by amine coupling using the Biacore amine coupling kit (GE Healthcare) following the manufacturer's protocols. LdcI was injected at 200 nM in 10 mM NaAc buffer at pH 3.5 over an activated surface, whereas RavA/RavAΔLARA was injected at 200 nM in 10 mM NaAc buffer at pH 5 over an activated surface. One flow cell was immobilized with the ligand, whereas the other was activated and deactivated without protein immobilization (reference flow cell). To remove the effect of nonspecific binding to the chip surface, the sensorgrams in the reference flow cell were subtracted from the corresponding sensorgrams in the ligand immobilized flow cell. Sensorgrams were recorded by injecting the analyte (RavA, RavAΔLARA, or LARA domain in the case of immobilized LdcI or the LARA domain in the case of immobilized RavA or RavAΔLARA) at 20 μL min −1 flow rate in running buffer containing 10 mM Hepes, pH 7.5, 150 mM NaCl, 0.005% P20 surfactant, and 3 mM EDTA. The surface was regenerated between injections with a 1-min pulse of 2 M NaCl (or 2 M MgCl 2 if needed) in running buffer. The steadystate responses were plotted versus the corresponding analyte concentrations and the dissociation constants were derived by fitting the data to a Langmuir binding models by using BiaEvaluation 4.1 software (GE Healthcare).
Measuring LdcI Enzyme Kinetics Using Isothermal Titration Calorimetry. The effect of RavA on LdcI enzyme kinetics were investigated using an isothermal titration calorimetry (ITC) approach (3). The assays were performed using a MicroCal VP-ITC calorimeter at 25°C with a stirring speed of 310 rpm and a buffer consisting of 100 mM sodium MES, pH 6.5, 1 mM tris(2-carboxyethyl)phosphine-HCl (TCEP-HCl), 1 mM ATP, 0.25 mM MgCl 2 , and 0.1 mM pyridoxal-5′-phosphate (PLP). Various combinations of substrates and protein were added at the following final concentrations: RavA-250 nM, RavAΔLARA-250 nM, LdcI-25 nM, ppGpp-50 μM, and L-lysine-1 mM. The order of addition of various combinations of proteins and small molecules is indicated in Fig. 4 A-C. For each experiment, a single injection of 75 μL was made and the initial rates were calculated in ORIGIN 7.0 using ΔH apparent for L-lysine of −3;161 cal mol −1 . The intrinsic ATPase activity of RavA under these conditions was insufficient to generate a significant heat change and was, therefore, not considered in the rate calculations.
Sedimentation Velocity Analytical Ultracentrifugation. Sedimentation velocity analytical ultracentrifugation experiments were carried out at the Ultracentrifugation Service Facility at the Department of Biochemistry, University of Toronto. RavA (18 μM) and LdcI (40 μM) were mixed in a buffer containing 25 mM TrisHCl pH 8, 200 mM NaCl, 1 mM TCEP, and 0.1 mM PLP. The experiment was carried out using a Beckman Optima XL-A analytical ultracentrifuge with an An-60 Ti rotor spun at 15,000 rpm at 4°C. Data were analyzed using SEDNTERP (4) and SEDFIT (5).
Pull-Down Experiments. Escherichia coli DY330 strain, in which a Sequential Peptide Affinity (SPA) tag (6, 7) was fused to the 3′ end of the endogenous ravA gene, was used for pull-down experiments. The strain (2 L) was grown for 24 h in Terrific Broth complemented with 0.2% glucose to induce LdcI at 30°C. Cells were resuspended in SPA binding buffer (25 mM Tris-HCl pH 8, 200 mM NaCl, 0.2 mM EDTA, 0.5 mM DTT, 10 mM MgCl 2 , 2 mM ATP, 0.1 mM PLP, and 10% glycerol) with the addition of 5 mg∕mL of lysozyme and 0.5 mg∕mL deoxyribonuclease I and lysed by sonication. The soluble fraction was incubated with the anti-FLAG M2 agarose beads (2 mL) for 6 h. After washing, the beads were incubated overnight in the presence of 500 μL of TEV protease at 2 mg∕mL in 5 mL SPA binding buffer. The cleaved RavA-CBP (calmodulin binding peptide) was harvested from the supernatant after centrifugation. The RavA-LdcI complexes were analyzed by size exclusion chromatography using a Superose 6 column (GE Healthcare).
Media Shift Assays. A media shift assay was performed to test the in vivo effect of RavA on the inhibition of LdcI by ppGpp. Four E. coli strains were used: MG1655 ΔcadBA, MG1655 pST39-RavA & pT7-pol26 (WT + ravA), MG1655 pST39-RavAΔLARA & pT7-pol26 (WT + ravAΔLARA) and MG1655 pST39-RavA (K52Q) & pT7-pol26 (WT + ravA(K52Q)). The latter three strains overexpress RavA, RavAΔLARA, and RavA(K52Q), respectively, under T7 promoter. The pST39 plasmid is described in ref. 8 . The pT7-pol26 plasmid is required to express the T7 polymerase and is described in ref. 9 . Five hundred milliliters of each of the three strains was grown at 37°C in 40 mM [3- (N-morpholino) propanesulfonic acid] -[2-(N-morpholino)ethanesulfonic acid] (MOPS-MES) defined rich media (10), pH 5, 1.32 mM K 2 HPO 4 , 1× ACGU (0.2 mM of each of Adenine, Cytosine, Guanine, and Uracil), 50 ng∕mL of each of the 20 amino acids, 0.1% ðwt∕volÞ D-glucose, and 30 mM lysine. After an OD 600 of 0.2 was reached, 1 mM IPTG was added to the cell cultures to induce the overexpression of RavA, RavAΔLARA, or RavA(K52Q). Cells were then incubated at 37°C for 1 h to obtain a final OD 600 of 0.4-0.5. Cells were pelleted at 5;000 × g for 10 min and washed once in the following minimal media: 5 mM MES, pH 5, 1.32 mM K 2 HPO 4 , 1× ACGU, and 0.001% glucose. Cells were pelleted again and resuspended in the same minimal media with 30 mM lysine. Postshift cells were incubated at 37°C for 2 h. OD 600 and pH of the media were measured every 30 min. Protein levels were checked by Western blot analysis.
Crystallization. Twenty-four screening conditions were prepared in 24-well crystallization plates (Hampton research). All conditions contained 0.1 M MES, pH 6.5, 2 mM ATP, and 10 mM MgCl 2 . The concentrations of ammonium sulfate (AS) and glycerol were gradually varied ([AS] varied from 0.1 to 0.6 M with an increment of 0.1 M; [Glycerol] varied from 10 to 40 % with an increment of 10%). One microliter of crystallization solution was added to 1 μL of 9 mg∕mL RavA protein. The reservoir contained 600 μL of crystallization solution. Crystals typically grew overnight after equilibration at 20°C. The largest crystals grew at low concentrations of AS and glycerol (typically at 0.2-0.3 M AS and 10% glycerol). A single crystal was transferred gradually from its original drop to a preequilibrated drop containing higher concentrations of AS and glycerol: starting from 0.3 M AS and 10% glycerol followed by 0.4 M AS and 20% glycerol followed by 0.5 M AS and 30% glycerol and ending with 0.6 M AS and 40% glycerol; the crystal was kept for about 12 h in each drop. This procedure also allowed for the dehydration of crystals which were then mounted on cryoloops (Hampton), flash frozen at 100 K, and placed for diffraction experiments. To derivatize the crystals, crystals were soaked in the presence of 5 mM ethyl mercury thiosalicylate (EMTS) for 45 min in the last dehydration step.
Data Collection and Processing. Diffraction data were collected on ID14-EH4 beamline for the native dataset and BM14 beamline for the derivative dataset at the European Synchrotron Radiation Facility in Grenoble, France. Data were processed with HKL2000 (11). Crystals contained one monomer per asymmetric unit in two possible space groups P6 1 or P6 5 . The best native dataset extended to a resolution of 2.9 Å, and the best derivative crystal dataset extended to 3.5-Å resolution. Molecular replacement phasing using AAA+ module from Rhodobacter capsulatus magnesium chelatase BchI (PDB ID code 1G8P) (12) was not successful. Therefore, the RavA crystal structure was solved using single isomorphous replacement with anomalous scattering (SIRAS) method. Five Hg sites were located in the asymmetric unit using ShelXD (13) . SHARP (14) was used to refine the sites and calculate the initial phases. The quality of the experimentally phased electron density maps calculated after running the SHARP procedure in both possible space groups gave the correct space group clearly as P6 5 . The map was further improved by solvent flattening using DM (15) with 67% solvent content. Model visualization and building was done with Coot (16) and refinement with REFMAC (17) . The geometry of the final model was checked with MolProbity (18) . Crystallographic details and refinement statistics are summarized in Table S1 . The coordinates have been deposited in the protein structure database under PDB ID code 3NBX.
Negative Staining Electron Microscopy. Prior to observation, the protein sample was supplemented with 1 mM ADP and incubated for 10 min. For preparation of negatively stained grids, the sample was applied to the clean side of a thin carbon film on carbonmica interface. The carbon film with the absorbed sample was floated on a drop of 2% ðwt∕volÞ uranyl acetate solution. A 400-mesh copper grid was put on top of the floating carbon film, and the whole setup was turned upside down and used to catch a second layer of carbon film floating on another drop of uranyl acetate. Prepared this way, the sample was entirely and uniformly stained and trapped between two thin layers of carbon. The grids were observed under low-dose conditions with a JEOL 1200 EX II transmission electron microscope with a tungsten filament at 100 kV. Images were recorded on Kodak SO-163 films at a nominal magnification of 40;000×. Selected negatives were then digitized on a Zeiss scanner (Photoscan TD) at a step size of 7 micrometers giving a pixel size of 1.75 Å at the specimen level, and binned to 3.5 Å∕pixel. Image processing was carried out on a Linux workstation using EMAN software package (19) for particle selection, CTFFIND (20) for contrast-transfer-function determination, bsoft (21) for correction, Imagic (22) for classification and angular reconstitution, and Spider (23, 24) for projection matching. URO (25) and its graphical version VEDA (http:// mem.ibs.fr/VEDA) were used for crystal structure fitting.
Image Analysis. A generous semiautomatic particle selection with the EMAN boxer routine led to an extraction of a total of 23,000 individual particle subframes of 80 × 80 pixels that were contrasttransfer-function corrected with CTFFIND and low-path-filtered at 18-Å resolution. Subsequent data processing was performed with the Imagic package. The dataset was translationally but not rotationally aligned relative to the rotationally averaged total sum of the individual images. The aligned dataset was subjected to multivariate statistical analysis (MSA), which clearly demonstrated the presence of 6-fold symmetric oligomers. Characteristic class averages were then used as a set of references for multireference alignment (MRA) followed by MSA and classification. Consistent with the our prior observations (1) based on a visual inspection of first RavA-ADP images, class averages manifested a variety of different shapes and sizes that do not correspond to projections of a unique three-dimensional object. Indeed, although the majority of RavA-ADP oligomers are hexameric, lower level oligomeric species are also present. This inhomogeneity complicates the image analysis because, although the top views and slightly tilted views of the hexameric species could be unambiguously identified, projections of smaller oligomers could sometimes be misinterpreted as side views or highly tilted views. After several rounds of MRA, MSA, and classification, class averages convincingly representing the hexameric species were selected to generate an initial model of the RavA-ADP hexamer by angular reconstitution with an imposed C6 symmetry, whereas images segregated into classes of unambiguously smaller particles were excluded from further analysis. An intermediate 3D model obtained after several iterative cycles of 3D-reconstruction and anchor-set refinement was projected into the asymmetric triangle for the C6 symmetry to provide a set of 3D-centered references for new rounds of MRA and angular reconstitution. Refinement of the 3D model was done in parallel in EMAN and Imagic and led to similar reconstructions, which showed a well-defined compact globular core of the hexamer and a less dense tip. This core represented the six AAA+ modules of RavA symmetrically arranged around a central pore. The reconstruction was of sufficient quality to place the atomic structure of the RavA monomer in the electron microscopy map with the help of the VEDA software. This preliminary fitting indicated that the tip was located precisely at the position of the triple helical domain but was too short to accommodate the LARA domain as a whole. Thus, a set of models with a different tilt of the LARA domain in respect to the C6-symmetry axis was created and used for further refinement by projection matching with Spider software, which allowed a better definition of the LARA domain protrusion and led to a final reconstruction. The resolution of the reconstruction was estimated via Fourier shell correlation to be around 25 Å according to the 0.5 threshold.
The crystal structure of the RavA monomer was then docked into this EM density map of the hexamer with VEDA; the resolution of the fit was limited to 25 Å. To get a better insight into the docking precision, the variation of the correlation between the fit and the EM map upon rotation of the best fit around its principal axes of inertia is plotted in Fig. S2 . Whereas the correlation between this ab initio fit and the EM map of the RavA hexamer is 74%, the HslU based model of hexameric RavA fitted into the EM density according to the same procedure gave a correlation of 72%. This model can be easily obtained from the ab initio fit by a combination of small rotations of the monomer and the correlation difference lies within the uncertainty limit. Furthermore, the fit to HslU hexamer has the major advantage of preserving biologically relevant contacts between monomers.
A comparison of RavA structure with available structures in the Protein Data Bank using the program DALI revealed significant similarity between the structure of RavA AAA+ domain and the equivalent domain in many AAA+ ATPases. However, only a handful of these AAA+ proteins were solved as hexamers. The closest hexameric structures are (from the highest to the lowest Z-score): (i) ZraR sigma54 activator, (ii) HslU, (iii) RUVB-like helicase, and (iv) p97. Using these four proteins as a template, a model for RavA hexamer was built. These different models of RavA hexamers showed clashes in their structure with the least number of clashes obtained when using HslU and the ZraR sigma54 activator as templates. Also, the generated RavA hexameric model obtained using sigma54 activator, RUVB-like helicase, and p97 had a closed shape whereby the RavA legs were almost parallel to the z axis. This observation was in disagreement with the EM 3D reconstruction shown in Fig. 2B where RavA displays a more open conformation. The RavA model obtained using HslU as a template gave an open shape of the hexameric model and, hence, was in general agreement with the 3D EM model. Hence, the choice of HslU as a template to build the RavA hexameric model.
The fit of the hexameric RavA atomic model and of the crystal structure of LdcI into the EM density of RavA-LdcI complex that we previously published (1) was done in VEDA in the same way. The low resolution of the negative stain map of the RavA-LdcI complex results in a fit uncertainty of about 30 deg around the C6 symmetry axis of the RavA hexamer. Within this uncertainty, we favor the fit which places the LARA domain of RavA in the general vicinity of the ppGpp binding pocket of LdcI and thus corroborates the whole of our biochemical data. Fig. 2E . The nucleotide interacting residues from the same subunit are shown in cyan, whereas residues from the neighboring subunit are shown in light and dark gray as in Fig. 2E . alues in parentheses refer to the highest resolution shell. The various crystallographic parameters are defined as follows: R merge , Σ|I i − hIi|∕ΣI i , where I i is the intensity of the ith observation, hIi is the mean intensity of the reflection, and the summation extends over all data. R Cullis , Σ||F PH − F P | − F H |∕Σ|F PH − F P |, where F H is the calculated heavy atom structure factor contribution; phasing power, hF H i∕hEi, where E is the root mean square lack of closure; R cryst , Σ|F obs − F calc |∕ΣF obs , where F obs and F calc represent the observed and calculated structure factors, respectively. R free was calculated using 5.2% of the observed reflections excluded from refinement. Excluded data were randomly selected.
